메뉴 건너뛰기




Volumn 409, Issue 1-2, 2011, Pages 278-288

In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles

Author keywords

Anti tumor activity; Biodistribution; Cytotoxicity; Fatty acid derivative; PEGylation; Release

Indexed keywords

4 (N)STEAROYL GEMCITABINE; GEMCITABINE; GLYCEROL STEARATE; NANOCARRIER; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

EID: 79955012698     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.02.037     Document Type: Article
Times cited : (94)

References (30)
  • 2
    • 47949094392 scopus 로고    scopus 로고
    • Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting
    • J.L. Arias, L.H. Reddy, and P. Couvreur Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting Langmuir 24 2008 7512 7519
    • (2008) Langmuir , vol.24 , pp. 7512-7519
    • Arias, J.L.1    Reddy, L.H.2    Couvreur, P.3
  • 3
    • 70350443227 scopus 로고    scopus 로고
    • Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine
    • J.L. Arias, L.H. Reddy, and P. Couvreur Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine J. Drug Target. 17 2009 586 598
    • (2009) J. Drug Target. , vol.17 , pp. 586-598
    • Arias, J.L.1    Reddy, L.H.2    Couvreur, P.3
  • 5
    • 0036462584 scopus 로고    scopus 로고
    • Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
    • A.M. Bergman, H.M. Pinedo, and G.J. Peters Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine) Drug Resist. Updat. 5 2002 19 33
    • (2002) Drug Resist. Updat. , vol.5 , pp. 19-33
    • Bergman, A.M.1    Pinedo, H.M.2    Peters, G.J.3
  • 6
    • 33847627626 scopus 로고    scopus 로고
    • Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs
    • P. Brusa, M.L. Immordino, F. Rocco, and L. Cattel Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs Anticancer Res. 27 2007 195 199
    • (2007) Anticancer Res. , vol.27 , pp. 195-199
    • Brusa, P.1    Immordino, M.L.2    Rocco, F.3    Cattel, L.4
  • 8
    • 0021118703 scopus 로고
    • Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
    • T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv. Enzyme Regul. 22 1984 27 55
    • (1984) Adv. Enzyme Regul. , vol.22 , pp. 27-55
    • Chou, T.C.1    Talalay, P.2
  • 9
    • 33645326198 scopus 로고    scopus 로고
    • Lecithin-based cationic nanoparticles as a potential DNA delivery system
    • Z. Cui, F. Qiu, and B.R. Sloat Lecithin-based cationic nanoparticles as a potential DNA delivery system Int. J. Pharm. 313 2006 206 213
    • (2006) Int. J. Pharm. , vol.313 , pp. 206-213
    • Cui, Z.1    Qiu, F.2    Sloat, B.R.3
  • 10
    • 0027275566 scopus 로고
    • Physiological parameters in laboratory animals and humans
    • DOI 10.1023/A:1018943613122
    • B. Davies, and T. Morris Physiological parameters in laboratory animals and humans Pharm. Res. 10 1993 1093 1095 (Pubitemid 23211439)
    • (1993) Pharmaceutical Research , vol.10 , Issue.7 , pp. 1093-1095
    • Davies, B.1    Morris, T.2
  • 11
    • 79953054576 scopus 로고    scopus 로고
    • The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
    • 10.1016/j.addr.2010.04.009
    • J. Fang, H. Nakamura, and H. Maeda The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Deliv. Rev 2010 10.1016/j.addr.2010.04.009
    • (2010) Adv. Drug Deliv. Rev
    • Fang, J.1    Nakamura, H.2    Maeda, H.3
  • 13
    • 0142219312 scopus 로고    scopus 로고
    • Nucleoside Transporter Profiles in Human Pancreatic Cancer Cells: Role of hCNT1 in 2′,2′-Difluorodeoxycytidine-Induced Cytotoxicity
    • J. Garcia-Manteiga, M. Molina-Arcas, F.J. Casado, A. Mazo, and M. Pastor-Anglada Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2′,2′-difluorodeoxycytidine- induced cytotoxicity Clin. Cancer Res. 9 2003 5000 5008 (Pubitemid 37323307)
    • (2003) Clinical Cancer Research , vol.9 , Issue.13 , pp. 5000-5008
    • Garcia-Manteiga, J.1    Molina-Arcas, M.2    Casado, F.J.3    Mazo, A.4    Pastor-Anglada, M.5
  • 14
    • 0033615679 scopus 로고    scopus 로고
    • Selective protection of 2′,2′-difluorodeoxycytidine (Gemcitabine)
    • Z. Guo, and J.M. Gallo Selective protection of 2′,2′- difluorodeoxycytidine (Gemcitabine) J. Org. Chem. 64 1999 8319 8322
    • (1999) J. Org. Chem. , vol.64 , pp. 8319-8322
    • Guo, Z.1    Gallo, J.M.2
  • 15
    • 9644302465 scopus 로고    scopus 로고
    • Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs
    • DOI 10.1016/j.jconrel.2004.09.001, PII S0168365904004341
    • M.L. Immordino, P. Brusa, F. Rocco, S. Arpicco, M. Ceruti, and L. Cattel Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs J. Control. Release 100 2004 331 346 (Pubitemid 39572916)
    • (2004) Journal of Controlled Release , vol.100 , Issue.3 , pp. 331-346
    • Immordino, M.L.1    Brusa, P.2    Rocco, F.3    Arpicco, S.4    Ceruti, M.5    Cattel, L.6
  • 16
    • 0035979950 scopus 로고    scopus 로고
    • Wetting and absorbency of nonionic surfactant solutions on cotton fabrics
    • DOI 10.1016/S0927-7757(01)00653-7, PII S0927775701006537
    • C. Kim, and Y.-L. Hsieh Wetting and absorbency of nonionic surfactant solutions on cotton fabrics Colloids Surf. A: Physicochem. Eng. Aspects 187-188 2001 385 397 (Pubitemid 32619174)
    • (2001) Colloids and Surfaces A: Physicochemical and Engineering Aspects , vol.187-188 , pp. 385-397
    • Kim, C.1    Hsieh, Y.-L.2
  • 17
    • 33746858503 scopus 로고    scopus 로고
    • Pancreatic cancer: From bench to 5-year survival
    • DOI 10.1097/01.mpa.0000229010.62538.f2, PII 0000667620060800000002
    • J. Kleeff, C. Michalski, H. Friess, and M.W. Buchler Pancreatic cancer: from bench to 5-year survival Pancreas 33 2006 111 118 (Pubitemid 44174558)
    • (2006) Pancreas , vol.33 , Issue.2 , pp. 111-118
    • Kleeff, J.1    Michalski, C.2    Friess, H.3    Buchler, M.W.4
  • 19
    • 33750554489 scopus 로고    scopus 로고
    • Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine
    • DOI 10.1097/01.cad.0000236303.97467.49, PII 0000181320061100000009
    • P. Pappas, D. Mavroudis, M. Nikolaidou, V. Georgoulias, and M. Marselos Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine Anticancer Drugs 17 2006 1185 1191 (Pubitemid 44673399)
    • (2006) Anti-Cancer Drugs , vol.17 , Issue.10 , pp. 1185-1191
    • Pappas, P.1    Mavroudis, D.2    Nikolaidou, M.3    Georgoulias, V.4    Marselos, M.5
  • 20
    • 75849117073 scopus 로고    scopus 로고
    • Novel targets for pancreatic cancer therapy
    • P.A. Philip Novel targets for pancreatic cancer therapy Surg. Oncol. Clin. N. Am. 19 2010 419 429
    • (2010) Surg. Oncol. Clin. N. Am. , vol.19 , pp. 419-429
    • Philip, P.A.1
  • 21
    • 22244438547 scopus 로고    scopus 로고
    • Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft
    • DOI 10.1158/0008-5472.CAN-05-0602
    • G. Pratesi, G. Petrangolini, M. Tortoreto, A. Addis, S. Belluco, A. Rossini, S. Selleri, C. Rumio, S. Menard, and A. Balsari Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft Cancer Res. 65 2005 6388 6393 (Pubitemid 40994426)
    • (2005) Cancer Research , vol.65 , Issue.14 , pp. 6388-6393
    • Pratesi, G.1    Petrangolini, G.2    Tortoreto, M.3    Addis, A.4    Belluco, S.5    Rossini, A.6    Selleri, S.7    Rumio, C.8    Menard, S.9    Balsari, A.10
  • 22
    • 36148942471 scopus 로고    scopus 로고
    • A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types
    • DOI 10.1016/j.jconrel.2007.08.018, PII S0168365907004245
    • L.H. Reddy, C. Dubernet, S.L. Mouelhi, P.E. Marque, D. Desmaele, and P. Couvreur A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types J. Control. Release 124 2007 20 27 (Pubitemid 350103730)
    • (2007) Journal of Controlled Release , vol.124 , Issue.1-2 , pp. 20-27
    • Reddy, L.H.1    Dubernet, C.2    Mouelhi, S.L.3    Marque, P.E.4    Desmaele, D.5    Couvreur, P.6
  • 24
    • 70849127008 scopus 로고    scopus 로고
    • Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles
    • B.R. Sloat, M.A. Sandoval, A.M. Hau, Y. He, and Z. Cui Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles J. Control. Release 141 2010 93 100
    • (2010) J. Control. Release , vol.141 , pp. 93-100
    • Sloat, B.R.1    Sandoval, M.A.2    Hau, A.M.3    He, Y.4    Cui, Z.5
  • 25
    • 34648825412 scopus 로고    scopus 로고
    • Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules
    • DOI 10.1016/j.ijpharm.2007.06.006, PII S037851730700498X, New Trends in Drug Delivery Systems
    • B. Stella, S. Arpicco, F. Rocco, V. Marsaud, J.M. Renoir, L. Cattel, and P. Couvreur Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules Int. J. Pharm. 344 2007 71 77 (Pubitemid 47464827)
    • (2007) International Journal of Pharmaceutics , vol.344 , Issue.1-2 , pp. 71-77
    • Stella, B.1    Arpicco, S.2    Rocco, F.3    Marsaud, V.4    Renoir, J.-M.5    Cattel, L.6    Couvreur, P.7
  • 26
    • 33846410793 scopus 로고
    • Predicting and controlling colloid suspension stability using electrophoretic mobility and particle size measurements
    • S. Sugrue Predicting and controlling colloid suspension stability using electrophoretic mobility and particle size measurements Am. Lab. 24 1992 64 71
    • (1992) Am. Lab. , vol.24 , pp. 64-71
    • Sugrue, S.1
  • 28
    • 61549106604 scopus 로고    scopus 로고
    • Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model
    • C.X. Wang, L.S. Huang, L.B. Hou, L. Jiang, Z.T. Yan, Y.L. Wang, and Z.L. Chen Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model Brain Res. 1261 2009 91 99
    • (2009) Brain Res. , vol.1261 , pp. 91-99
    • Wang, C.X.1    Huang, L.S.2    Hou, L.B.3    Jiang, L.4    Yan, Z.T.5    Wang, Y.L.6    Chen, Z.L.7
  • 29
    • 68649111125 scopus 로고    scopus 로고
    • Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel
    • N. Yanasarn, B.R. Sloat, and Z. Cui Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel Int. J. Pharm. 379 2009 174 180
    • (2009) Int. J. Pharm. , vol.379 , pp. 174-180
    • Yanasarn, N.1    Sloat, B.R.2    Cui, Z.3
  • 30
    • 77955519181 scopus 로고    scopus 로고
    • PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
    • Y. Zhang, M. Huo, J. Zhou, and S. Xie PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel Comput. Methods Programs Biomed. 99 2010 306 314
    • (2010) Comput. Methods Programs Biomed. , vol.99 , pp. 306-314
    • Zhang, Y.1    Huo, M.2    Zhou, J.3    Xie, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.